Close

Form 424B3 ROYAL BANK OF CANADA

September 30, 2022 12:36 PM EDT

Supplement dated September 27, 2022
to the pricing supplements, each dated September 23, 2022,
to the Product Prospectus Supplement No. ERN-ETF-1 Dated
March 3, 2022, the Prospectus Supplement Dated September
14, 2021 and the Prospectus, Dated September 14, 2021
(each, a “Note Prospectus”)
Filed pursuant to Rule 424(b)(3)
Registration Statement 333-259205
 
   
 
Royal Bank of Canada
Notes Linked to a Basket of Closed-End Funds, due September 26, 2024
Global Medium-Term Notes, Series I
CUSIPS: 78015QBX8 and 78015QBY6
(the “notes”)
This document (the “supplement”) supplements each Note Prospectus. Capitalized terms used but not defined in this supplement have the meanings set forth in each Note Prospectus.
The Initial Price for each Basket Component was determined after the close of trading on September 27, 2022, in the manner contemplated by each Note Prospectus.  The Initial Price for each Basket Component is set forth in the table below:
 
Basket Component
 
Ticker
 
Initial Price
 
BlackRock Energy & Resources Trust
 
BGR
 
$10.45
 
BlackRock Innovation and Growth Trust
 
BIGZ
 
$7.20
 
BlackRock Enhanced Global Dividend Trust
 
BOE
 
$8.83
 
BlackRock Science and Technology Trust II
 
BSTZ
 
$17.98
 
BlackRock Debt Strategies Fund, Inc.
 
DSU
 
$8.93
 
Eaton Vance Enhanced Equity Income Fund
 
EOI
 
$14.34
 
The Gabelli Dividend & Income Trust
 
GDV
 
$19.18
 
Western Asset High Income Opportunity Fund Inc.
 
HIO
 
$3.75
 
PGIM High Yield Bond Fund, Inc.
 
ISD
 
$11.66
 
Nuveen Credit Strategies Income Fund
 
JQC
 
$5.06
 
Nuveen Real Asset Income and Growth Fund
 
JRI
 
$11.40
 
Nuveen Floating Rate Income Opportunity Fund
 
JRO
 
$8.05
 
MainStay CBRE Global Infrastructure Megatrends Fund
 
MEGI
 
$13.51
 
Tekla Healthcare Opportunities Fund
 
THQ
 
$18.20
 
Tri-Continental Corporation
 
TY
 
$25.96


Documentation

You should read this supplement, together with the documents listed below, which together contain the terms of the notes and supersede all prior or contemporaneous oral statements as well as any other written materials. You should carefully consider, among other things, the matters set forth in the section "Selected Risk Considerations" beginning on page P-8 of the applicable Pricing Supplement, and “Additional Risk Factors Specific to the Notes” beginning on page PS-6 of product supplement ERN-ETF-1, and on page S-2 of the prospectus supplement, as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting, and other advisors before you make any invest decision relating to the notes.

You may access these documents on the SEC website at www.sec.gov as follows:

Pricing Supplement relating to CUSIP 78015QBX8, dated September 23, 2022:
Pricing Supplement relating to CUSIP 78015QBY6, dated September 23, 2022:
Product Prospectus Supplement ERN-ETF-1 dated March 3, 2022:
Prospectus Supplement dated September 14, 2021:
Prospectus dated September 14, 2021:

Our Central Index Key, or CIK, on the SEC website is 1000275. Unless otherwise indicated or unless the context requires otherwise, all references in this supplement to “we,” “us,” “our,” or similar references are to Royal Bank of Canada.





Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings